Renal Cancer - Results from #1940

Comparison of robot-assisted partial nephrectomy for complex (RENAL scores ≥10) and non-complex renal tumors: A single-center experience. July 22, 2021

Presence of Urinary Exosomes for Liquid Biopsy of Clear Cell Renal Cell Carcinoma: Protocol for a Pilot Feasibility Study. July 22, 2021

Role of Imaging in Renal Cell Carcinoma: A Multidisciplinary Perspective. July 21, 2021

Kidney Transplant Outcomes in Indigenous People of the Northern Great Plains of the United States. July 21, 2021

Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials. July 20, 2021

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma. July 20, 2021

Haplotype-resolved germline and somatic alterations in renal medullary carcinomas. July 20, 2021

Evaluation of Insurance Coverage and Cancer Stage at Diagnosis Among Low-Income Adults With Renal Cell Carcinoma After Passage of the Patient Protection and Affordable Care Act. July 19, 2021

Serum and urine analysis with gold nanoparticle-assisted laser desorption/ionization mass spectrometry for renal cell carcinoma metabolic biomarkers discovery. July 19, 2021

Cystatin C predicts renal function impairment after partial or radical tumor nephrectomy. July 19, 2021

Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis. July 16, 2021

Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma. July 16, 2021

HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration. July 15, 2021

Sunitinib with photoirradiation-mediated reactive oxygen species generation induces apoptosis of renal cell carcinoma cells. July 15, 2021

Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up. July 14, 2021

Evaluation of response to tyrosine kinase inhibitors in renal cell carcinoma patients based on expression of miR-99b, -144, -210, -222, -302а and -377 in tumor tissue. July 13, 2021

Nephrectomy improves the survival of metastatic renal cell cancer patients with moderate to good performance status-results from a Finnish nation-wide population-based study from 2005 to 2010. July 13, 2021

Nephrectomy Delay of More than 10 Weeks from Diagnosis Is Associated with Decreased Overall Survival in pT3 RCC. July 13, 2021

Cholesterol auxotrophy as a targetable vulnerability in clear cell renal cell carcinoma. July 12, 2021

Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial. July 12, 2021

Page 98 of 456